nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—ADRA2A—epilepsy syndrome	0.161	0.434	CbGaD
Prazosin—ABCG2—epilepsy syndrome	0.148	0.399	CbGaD
Prazosin—ABCB1—epilepsy syndrome	0.0618	0.166	CbGaD
Prazosin—SLC22A1—Midazolam—epilepsy syndrome	0.0377	0.17	CbGbCtD
Prazosin—CYP1A1—Propofol—epilepsy syndrome	0.0314	0.142	CbGbCtD
Prazosin—CYP1A1—Phenobarbital—epilepsy syndrome	0.03	0.135	CbGbCtD
Prazosin—ABCB1—Levetiracetam—epilepsy syndrome	0.0255	0.115	CbGbCtD
Prazosin—ABCB1—Clobazam—epilepsy syndrome	0.0177	0.0799	CbGbCtD
Prazosin—ABCB1—Lamotrigine—epilepsy syndrome	0.017	0.0769	CbGbCtD
Prazosin—ABCB1—Carbamazepine—epilepsy syndrome	0.0147	0.0662	CbGbCtD
Prazosin—ABCB1—Phenytoin—epilepsy syndrome	0.0131	0.0593	CbGbCtD
Prazosin—ABCB1—Phenobarbital—epilepsy syndrome	0.0117	0.0529	CbGbCtD
Prazosin—ABCB1—Midazolam—epilepsy syndrome	0.0116	0.0522	CbGbCtD
Prazosin—ABCB1—Diazepam—epilepsy syndrome	0.0111	0.0501	CbGbCtD
Prazosin—HTR1D—meninx—epilepsy syndrome	0.00815	0.107	CbGeAlD
Prazosin—MT3—telencephalic ventricle—epilepsy syndrome	0.00633	0.083	CbGeAlD
Prazosin—MT3—ganglion—epilepsy syndrome	0.00394	0.0516	CbGeAlD
Prazosin—MT3—hindbrain—epilepsy syndrome	0.00299	0.0392	CbGeAlD
Prazosin—KCNH6—ganglion—epilepsy syndrome	0.00281	0.0368	CbGeAlD
Prazosin—HTR1D—telencephalic ventricle—epilepsy syndrome	0.00187	0.0245	CbGeAlD
Prazosin—MT3—brainstem—epilepsy syndrome	0.00171	0.0224	CbGeAlD
Prazosin—MT3—forebrain—epilepsy syndrome	0.00165	0.0217	CbGeAlD
Prazosin—HTR1A—telencephalic ventricle—epilepsy syndrome	0.00156	0.0204	CbGeAlD
Prazosin—MT3—telencephalon—epilepsy syndrome	0.00152	0.0199	CbGeAlD
Prazosin—MT3—medulla oblongata—epilepsy syndrome	0.0012	0.0157	CbGeAlD
Prazosin—KCNH6—forebrain—epilepsy syndrome	0.00118	0.0154	CbGeAlD
Prazosin—SLC22A1—ganglion—epilepsy syndrome	0.00117	0.0154	CbGeAlD
Prazosin—HTR1D—ganglion—epilepsy syndrome	0.00116	0.0152	CbGeAlD
Prazosin—SLC22A3—tongue—epilepsy syndrome	0.00111	0.0145	CbGeAlD
Prazosin—KCNH6—telencephalon—epilepsy syndrome	0.00108	0.0142	CbGeAlD
Prazosin—MT3—spinal cord—epilepsy syndrome	0.00107	0.014	CbGeAlD
Prazosin—HTR1A—ganglion—epilepsy syndrome	0.00097	0.0127	CbGeAlD
Prazosin—MT3—head—epilepsy syndrome	0.000947	0.0124	CbGeAlD
Prazosin—KCNH7—head—epilepsy syndrome	0.000947	0.0124	CbGeAlD
Prazosin—MT3—nervous system—epilepsy syndrome	0.000898	0.0118	CbGeAlD
Prazosin—KCNH7—nervous system—epilepsy syndrome	0.000898	0.0118	CbGeAlD
Prazosin—MT3—central nervous system—epilepsy syndrome	0.000865	0.0113	CbGeAlD
Prazosin—KCNH7—central nervous system—epilepsy syndrome	0.000865	0.0113	CbGeAlD
Prazosin—MT3—cerebellum—epilepsy syndrome	0.000845	0.0111	CbGeAlD
Prazosin—KCNH7—cerebellum—epilepsy syndrome	0.000845	0.0111	CbGeAlD
Prazosin—HTR1A—hindbrain—epilepsy syndrome	0.000736	0.00963	CbGeAlD
Prazosin—Doxazosin—ADRA2A—epilepsy syndrome	0.000716	0.317	CrCbGaD
Prazosin—MT3—brain—epilepsy syndrome	0.000686	0.00899	CbGeAlD
Prazosin—KCNH7—brain—epilepsy syndrome	0.000686	0.00899	CbGeAlD
Prazosin—ADRA1A—hindbrain—epilepsy syndrome	0.000678	0.00888	CbGeAlD
Prazosin—KCNH6—head—epilepsy syndrome	0.000675	0.00884	CbGeAlD
Prazosin—ADRA1D—forebrain—epilepsy syndrome	0.000653	0.00855	CbGeAlD
Prazosin—KCNH6—nervous system—epilepsy syndrome	0.00064	0.00838	CbGeAlD
Prazosin—KCNH6—central nervous system—epilepsy syndrome	0.000616	0.00807	CbGeAlD
Prazosin—ADRA1D—telencephalon—epilepsy syndrome	0.0006	0.00786	CbGeAlD
Prazosin—Doxazosin—CYP2C19—epilepsy syndrome	0.000518	0.229	CrCbGaD
Prazosin—HTR1D—brainstem—epilepsy syndrome	0.000506	0.00662	CbGeAlD
Prazosin—SLC22A1—forebrain—epilepsy syndrome	0.000493	0.00645	CbGeAlD
Prazosin—KCNH6—brain—epilepsy syndrome	0.000489	0.0064	CbGeAlD
Prazosin—HTR1D—forebrain—epilepsy syndrome	0.000488	0.00639	CbGeAlD
Prazosin—SLC22A1—telencephalon—epilepsy syndrome	0.000453	0.00593	CbGeAlD
Prazosin—HTR1D—telencephalon—epilepsy syndrome	0.000449	0.00588	CbGeAlD
Prazosin—HTR1A—brainstem—epilepsy syndrome	0.000422	0.00552	CbGeAlD
Prazosin—HTR1A—forebrain—epilepsy syndrome	0.000407	0.00533	CbGeAlD
Prazosin—ADRA1A—brainstem—epilepsy syndrome	0.000389	0.00509	CbGeAlD
Prazosin—Doxazosin—CYP2D6—epilepsy syndrome	0.000384	0.17	CrCbGaD
Prazosin—ADRA1B—head—epilepsy syndrome	0.000382	0.00501	CbGeAlD
Prazosin—ADRA1A—forebrain—epilepsy syndrome	0.000375	0.00491	CbGeAlD
Prazosin—HTR1A—telencephalon—epilepsy syndrome	0.000374	0.0049	CbGeAlD
Prazosin—ADRA1D—head—epilepsy syndrome	0.000374	0.0049	CbGeAlD
Prazosin—Terazosin—ABCB1—epilepsy syndrome	0.000368	0.163	CrCbGaD
Prazosin—ADRA1B—nervous system—epilepsy syndrome	0.000362	0.00475	CbGeAlD
Prazosin—KCNH2—forebrain—epilepsy syndrome	0.000362	0.00474	CbGeAlD
Prazosin—ADRA1D—nervous system—epilepsy syndrome	0.000354	0.00464	CbGeAlD
Prazosin—ADRA1B—central nervous system—epilepsy syndrome	0.000349	0.00457	CbGeAlD
Prazosin—ORM1—spinal cord—epilepsy syndrome	0.000346	0.00454	CbGeAlD
Prazosin—ADRA1A—telencephalon—epilepsy syndrome	0.000345	0.00452	CbGeAlD
Prazosin—ADRA1D—central nervous system—epilepsy syndrome	0.000341	0.00447	CbGeAlD
Prazosin—KCNH2—telencephalon—epilepsy syndrome	0.000333	0.00436	CbGeAlD
Prazosin—HTR1D—midbrain—epilepsy syndrome	0.000322	0.00422	CbGeAlD
Prazosin—ABCG2—telencephalon—epilepsy syndrome	0.000296	0.00388	CbGeAlD
Prazosin—ORM1—nervous system—epilepsy syndrome	0.000292	0.00382	CbGeAlD
Prazosin—ADRA2A—forebrain—epilepsy syndrome	0.000285	0.00373	CbGeAlD
Prazosin—SLC22A1—head—epilepsy syndrome	0.000282	0.00369	CbGeAlD
Prazosin—ORM1—central nervous system—epilepsy syndrome	0.000281	0.00368	CbGeAlD
Prazosin—HTR1D—head—epilepsy syndrome	0.000279	0.00366	CbGeAlD
Prazosin—ADRA1B—brain—epilepsy syndrome	0.000277	0.00363	CbGeAlD
Prazosin—Doxazosin—ABCB1—epilepsy syndrome	0.000274	0.121	CrCbGaD
Prazosin—ADRA1D—brain—epilepsy syndrome	0.000271	0.00355	CbGeAlD
Prazosin—SLC22A3—head—epilepsy syndrome	0.00027	0.00353	CbGeAlD
Prazosin—HTR1A—midbrain—epilepsy syndrome	0.000269	0.00352	CbGeAlD
Prazosin—SLC22A1—nervous system—epilepsy syndrome	0.000267	0.0035	CbGeAlD
Prazosin—HTR1D—nervous system—epilepsy syndrome	0.000265	0.00347	CbGeAlD
Prazosin—ADRA2A—telencephalon—epilepsy syndrome	0.000262	0.00343	CbGeAlD
Prazosin—HTR1A—spinal cord—epilepsy syndrome	0.000262	0.00343	CbGeAlD
Prazosin—KCNH2—medulla oblongata—epilepsy syndrome	0.000262	0.00343	CbGeAlD
Prazosin—SLC22A1—central nervous system—epilepsy syndrome	0.000257	0.00337	CbGeAlD
Prazosin—SLC22A3—nervous system—epilepsy syndrome	0.000256	0.00335	CbGeAlD
Prazosin—HTR1D—central nervous system—epilepsy syndrome	0.000255	0.00334	CbGeAlD
Prazosin—SLC22A3—central nervous system—epilepsy syndrome	0.000246	0.00322	CbGeAlD
Prazosin—KCNH2—midbrain—epilepsy syndrome	0.000239	0.00313	CbGeAlD
Prazosin—KCNH2—spinal cord—epilepsy syndrome	0.000233	0.00306	CbGeAlD
Prazosin—HTR1A—head—epilepsy syndrome	0.000233	0.00305	CbGeAlD
Prazosin—ABCG2—medulla oblongata—epilepsy syndrome	0.000233	0.00305	CbGeAlD
Prazosin—HTR1A—nervous system—epilepsy syndrome	0.000221	0.00289	CbGeAlD
Prazosin—ADRA1A—head—epilepsy syndrome	0.000215	0.00281	CbGeAlD
Prazosin—ABCG2—midbrain—epilepsy syndrome	0.000213	0.00279	CbGeAlD
Prazosin—HTR1A—central nervous system—epilepsy syndrome	0.000213	0.00278	CbGeAlD
Prazosin—HTR1A—cerebellum—epilepsy syndrome	0.000208	0.00272	CbGeAlD
Prazosin—ABCG2—spinal cord—epilepsy syndrome	0.000208	0.00272	CbGeAlD
Prazosin—KCNH2—head—epilepsy syndrome	0.000207	0.00272	CbGeAlD
Prazosin—ADRA2A—medulla oblongata—epilepsy syndrome	0.000206	0.0027	CbGeAlD
Prazosin—SLC22A1—brain—epilepsy syndrome	0.000204	0.00268	CbGeAlD
Prazosin—ADRA1A—nervous system—epilepsy syndrome	0.000204	0.00267	CbGeAlD
Prazosin—HTR1D—brain—epilepsy syndrome	0.000203	0.00265	CbGeAlD
Prazosin—KCNH2—nervous system—epilepsy syndrome	0.000197	0.00258	CbGeAlD
Prazosin—ADRA1A—central nervous system—epilepsy syndrome	0.000196	0.00257	CbGeAlD
Prazosin—SLC22A3—brain—epilepsy syndrome	0.000195	0.00256	CbGeAlD
Prazosin—ADRA1A—cerebellum—epilepsy syndrome	0.000192	0.00251	CbGeAlD
Prazosin—KCNH2—central nervous system—epilepsy syndrome	0.000189	0.00248	CbGeAlD
Prazosin—ADRA2A—midbrain—epilepsy syndrome	0.000188	0.00247	CbGeAlD
Prazosin—KCNH2—cerebellum—epilepsy syndrome	0.000185	0.00242	CbGeAlD
Prazosin—ADRA2A—spinal cord—epilepsy syndrome	0.000184	0.00241	CbGeAlD
Prazosin—CYP1A1—head—epilepsy syndrome	0.000175	0.00229	CbGeAlD
Prazosin—HTR1A—brain—epilepsy syndrome	0.000169	0.00221	CbGeAlD
Prazosin—CYP1A1—nervous system—epilepsy syndrome	0.000166	0.00217	CbGeAlD
Prazosin—ABCG2—cerebellum—epilepsy syndrome	0.000165	0.00216	CbGeAlD
Prazosin—ADRA2A—head—epilepsy syndrome	0.000163	0.00214	CbGeAlD
Prazosin—CYP1A1—central nervous system—epilepsy syndrome	0.00016	0.00209	CbGeAlD
Prazosin—ABCB1—forebrain—epilepsy syndrome	0.000159	0.00208	CbGeAlD
Prazosin—ADRA1A—brain—epilepsy syndrome	0.000156	0.00204	CbGeAlD
Prazosin—ADRA2A—nervous system—epilepsy syndrome	0.000155	0.00203	CbGeAlD
Prazosin—KCNH2—brain—epilepsy syndrome	0.00015	0.00197	CbGeAlD
Prazosin—ADRA2A—central nervous system—epilepsy syndrome	0.000149	0.00195	CbGeAlD
Prazosin—ABCB1—telencephalon—epilepsy syndrome	0.000146	0.00191	CbGeAlD
Prazosin—ADRA2A—cerebellum—epilepsy syndrome	0.000146	0.00191	CbGeAlD
Prazosin—ABCG2—brain—epilepsy syndrome	0.000134	0.00175	CbGeAlD
Prazosin—CYP1A1—brain—epilepsy syndrome	0.000127	0.00166	CbGeAlD
Prazosin—Dermatitis—Propofol—epilepsy syndrome	0.000122	0.000694	CcSEcCtD
Prazosin—Headache—Propofol—epilepsy syndrome	0.000122	0.00069	CcSEcCtD
Prazosin—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000121	0.000688	CcSEcCtD
Prazosin—Vomiting—Midazolam—epilepsy syndrome	0.000121	0.000685	CcSEcCtD
Prazosin—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000121	0.000685	CcSEcCtD
Prazosin—Asthenia—Felbamate—epilepsy syndrome	0.000121	0.000684	CcSEcCtD
Prazosin—Vision blurred—Pregabalin—epilepsy syndrome	0.000121	0.000684	CcSEcCtD
Prazosin—Arthralgia—Valproic Acid—epilepsy syndrome	0.00012	0.000683	CcSEcCtD
Prazosin—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.00012	0.000679	CcSEcCtD
Prazosin—Rash—Midazolam—epilepsy syndrome	0.00012	0.000679	CcSEcCtD
Prazosin—Dizziness—Fosphenytoin—epilepsy syndrome	0.00012	0.000679	CcSEcCtD
Prazosin—Dermatitis—Midazolam—epilepsy syndrome	0.00012	0.000679	CcSEcCtD
Prazosin—Urticaria—Carbamazepine—epilepsy syndrome	0.000119	0.000678	CcSEcCtD
Prazosin—Vomiting—Levetiracetam—epilepsy syndrome	0.000119	0.000676	CcSEcCtD
Prazosin—Epistaxis—Topiramate—epilepsy syndrome	0.000119	0.000676	CcSEcCtD
Prazosin—Alopecia—Gabapentin—epilepsy syndrome	0.000119	0.000675	CcSEcCtD
Prazosin—Discomfort—Valproic Acid—epilepsy syndrome	0.000119	0.000675	CcSEcCtD
Prazosin—Headache—Midazolam—epilepsy syndrome	0.000119	0.000675	CcSEcCtD
Prazosin—Pruritus—Felbamate—epilepsy syndrome	0.000119	0.000675	CcSEcCtD
Prazosin—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000119	0.000674	CcSEcCtD
Prazosin—Diarrhoea—Diazepam—epilepsy syndrome	0.000119	0.000674	CcSEcCtD
Prazosin—Ill-defined disorder—Pregabalin—epilepsy syndrome	0.000119	0.000673	CcSEcCtD
Prazosin—ADRA2A—brain—epilepsy syndrome	0.000118	0.00155	CbGeAlD
Prazosin—Rash—Levetiracetam—epilepsy syndrome	0.000118	0.000671	CcSEcCtD
Prazosin—Dermatitis—Levetiracetam—epilepsy syndrome	0.000118	0.00067	CcSEcCtD
Prazosin—Asthenia—Zonisamide—epilepsy syndrome	0.000118	0.00067	CcSEcCtD
Prazosin—Dry mouth—Valproic Acid—epilepsy syndrome	0.000118	0.000668	CcSEcCtD
Prazosin—Headache—Levetiracetam—epilepsy syndrome	0.000118	0.000666	CcSEcCtD
Prazosin—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000117	0.000663	CcSEcCtD
Prazosin—Dizziness—Vigabatrin—epilepsy syndrome	0.000117	0.000662	CcSEcCtD
Prazosin—Pruritus—Zonisamide—epilepsy syndrome	0.000116	0.00066	CcSEcCtD
Prazosin—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000116	0.000658	CcSEcCtD
Prazosin—Oedema—Valproic Acid—epilepsy syndrome	0.000116	0.000655	CcSEcCtD
Prazosin—Urticaria—Lamotrigine—epilepsy syndrome	0.000115	0.000655	CcSEcCtD
Prazosin—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000115	0.000655	CcSEcCtD
Prazosin—Bradycardia—Topiramate—epilepsy syndrome	0.000115	0.000655	CcSEcCtD
Prazosin—Malaise—Pregabalin—epilepsy syndrome	0.000115	0.000654	CcSEcCtD
Prazosin—Nausea—Propofol—epilepsy syndrome	0.000115	0.000654	CcSEcCtD
Prazosin—Tension—Gabapentin—epilepsy syndrome	0.000115	0.000653	CcSEcCtD
Prazosin—Vomiting—Fosphenytoin—epilepsy syndrome	0.000115	0.000653	CcSEcCtD
Prazosin—Diarrhoea—Felbamate—epilepsy syndrome	0.000115	0.000652	CcSEcCtD
Prazosin—Vertigo—Pregabalin—epilepsy syndrome	0.000115	0.000652	CcSEcCtD
Prazosin—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000115	0.000652	CcSEcCtD
Prazosin—Dizziness—Diazepam—epilepsy syndrome	0.000115	0.000652	CcSEcCtD
Prazosin—ABCB1—medulla oblongata—epilepsy syndrome	0.000115	0.0015	CbGeAlD
Prazosin—Syncope—Pregabalin—epilepsy syndrome	0.000115	0.000651	CcSEcCtD
Prazosin—Rash—Fosphenytoin—epilepsy syndrome	0.000114	0.000647	CcSEcCtD
Prazosin—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000114	0.000647	CcSEcCtD
Prazosin—Nervousness—Gabapentin—epilepsy syndrome	0.000114	0.000646	CcSEcCtD
Prazosin—Asthenia—Clonazepam—epilepsy syndrome	0.000114	0.000645	CcSEcCtD
Prazosin—Headache—Fosphenytoin—epilepsy syndrome	0.000113	0.000643	CcSEcCtD
Prazosin—Palpitations—Pregabalin—epilepsy syndrome	0.000113	0.000641	CcSEcCtD
Prazosin—Asthenia—Phenytoin—epilepsy syndrome	0.000113	0.000641	CcSEcCtD
Prazosin—Nausea—Midazolam—epilepsy syndrome	0.000113	0.00064	CcSEcCtD
Prazosin—Hallucination—Topiramate—epilepsy syndrome	0.000113	0.00064	CcSEcCtD
Prazosin—Tachycardia—Valproic Acid—epilepsy syndrome	0.000113	0.000639	CcSEcCtD
Prazosin—Diarrhoea—Zonisamide—epilepsy syndrome	0.000113	0.000639	CcSEcCtD
Prazosin—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000112	0.000638	CcSEcCtD
Prazosin—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000112	0.000638	CcSEcCtD
Prazosin—Pruritus—Clonazepam—epilepsy syndrome	0.000112	0.000636	CcSEcCtD
Prazosin—Vomiting—Vigabatrin—epilepsy syndrome	0.000112	0.000636	CcSEcCtD
Prazosin—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000112	0.000633	CcSEcCtD
Prazosin—Pruritus—Phenytoin—epilepsy syndrome	0.000111	0.000632	CcSEcCtD
Prazosin—Nausea—Levetiracetam—epilepsy syndrome	0.000111	0.000632	CcSEcCtD
Prazosin—Rash—Vigabatrin—epilepsy syndrome	0.000111	0.000631	CcSEcCtD
Prazosin—Dizziness—Felbamate—epilepsy syndrome	0.000111	0.000631	CcSEcCtD
Prazosin—Dermatitis—Vigabatrin—epilepsy syndrome	0.000111	0.00063	CcSEcCtD
Prazosin—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000111	0.000629	CcSEcCtD
Prazosin—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000111	0.000628	CcSEcCtD
Prazosin—Vision blurred—Gabapentin—epilepsy syndrome	0.000111	0.000627	CcSEcCtD
Prazosin—Headache—Vigabatrin—epilepsy syndrome	0.000111	0.000627	CcSEcCtD
Prazosin—Vomiting—Diazepam—epilepsy syndrome	0.00011	0.000626	CcSEcCtD
Prazosin—Rash—Diazepam—epilepsy syndrome	0.00011	0.000621	CcSEcCtD
Prazosin—Dermatitis—Diazepam—epilepsy syndrome	0.000109	0.000621	CcSEcCtD
Prazosin—Arthralgia—Pregabalin—epilepsy syndrome	0.000109	0.000618	CcSEcCtD
Prazosin—Ill-defined disorder—Gabapentin—epilepsy syndrome	0.000109	0.000617	CcSEcCtD
Prazosin—Dizziness—Zonisamide—epilepsy syndrome	0.000109	0.000617	CcSEcCtD
Prazosin—Headache—Diazepam—epilepsy syndrome	0.000109	0.000617	CcSEcCtD
Prazosin—Diarrhoea—Clonazepam—epilepsy syndrome	0.000109	0.000616	CcSEcCtD
Prazosin—Asthenia—Carbamazepine—epilepsy syndrome	0.000108	0.000612	CcSEcCtD
Prazosin—Diarrhoea—Phenytoin—epilepsy syndrome	0.000108	0.000611	CcSEcCtD
Prazosin—Discomfort—Pregabalin—epilepsy syndrome	0.000108	0.00061	CcSEcCtD
Prazosin—Nausea—Fosphenytoin—epilepsy syndrome	0.000108	0.00061	CcSEcCtD
Prazosin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000107	0.000608	CcSEcCtD
Prazosin—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000107	0.000607	CcSEcCtD
Prazosin—Vomiting—Felbamate—epilepsy syndrome	0.000107	0.000606	CcSEcCtD
Prazosin—Dry mouth—Pregabalin—epilepsy syndrome	0.000107	0.000604	CcSEcCtD
Prazosin—Pruritus—Carbamazepine—epilepsy syndrome	0.000106	0.000603	CcSEcCtD
Prazosin—Rash—Felbamate—epilepsy syndrome	0.000106	0.000601	CcSEcCtD
Prazosin—Dermatitis—Felbamate—epilepsy syndrome	0.000106	0.000601	CcSEcCtD
Prazosin—Malaise—Gabapentin—epilepsy syndrome	0.000106	0.0006	CcSEcCtD
Prazosin—Tinnitus—Topiramate—epilepsy syndrome	0.000106	0.0006	CcSEcCtD
Prazosin—Vertigo—Gabapentin—epilepsy syndrome	0.000105	0.000598	CcSEcCtD
Prazosin—Headache—Felbamate—epilepsy syndrome	0.000105	0.000597	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000105	0.000597	CcSEcCtD
Prazosin—Flushing—Topiramate—epilepsy syndrome	0.000105	0.000597	CcSEcCtD
Prazosin—Syncope—Gabapentin—epilepsy syndrome	0.000105	0.000597	CcSEcCtD
Prazosin—ABCB1—midbrain—epilepsy syndrome	0.000105	0.00137	CbGeAlD
Prazosin—Dizziness—Clonazepam—epilepsy syndrome	0.000105	0.000595	CcSEcCtD
Prazosin—Nausea—Vigabatrin—epilepsy syndrome	0.000105	0.000594	CcSEcCtD
Prazosin—Vomiting—Zonisamide—epilepsy syndrome	0.000105	0.000594	CcSEcCtD
Prazosin—Insomnia—Valproic Acid—epilepsy syndrome	0.000104	0.000593	CcSEcCtD
Prazosin—Oedema—Pregabalin—epilepsy syndrome	0.000104	0.000592	CcSEcCtD
Prazosin—Asthenia—Lamotrigine—epilepsy syndrome	0.000104	0.000591	CcSEcCtD
Prazosin—Dizziness—Phenytoin—epilepsy syndrome	0.000104	0.000591	CcSEcCtD
Prazosin—Rash—Zonisamide—epilepsy syndrome	0.000104	0.000589	CcSEcCtD
Prazosin—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000104	0.000588	CcSEcCtD
Prazosin—Palpitations—Gabapentin—epilepsy syndrome	0.000104	0.000588	CcSEcCtD
Prazosin—Dermatitis—Zonisamide—epilepsy syndrome	0.000104	0.000588	CcSEcCtD
Prazosin—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000104	0.000588	CcSEcCtD
Prazosin—Nausea—Diazepam—epilepsy syndrome	0.000103	0.000585	CcSEcCtD
Prazosin—Loss of consciousness—Gabapentin—epilepsy syndrome	0.000103	0.000585	CcSEcCtD
Prazosin—Headache—Zonisamide—epilepsy syndrome	0.000103	0.000585	CcSEcCtD
Prazosin—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000103	0.000584	CcSEcCtD
Prazosin—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000103	0.000584	CcSEcCtD
Prazosin—Pruritus—Lamotrigine—epilepsy syndrome	0.000103	0.000583	CcSEcCtD
Prazosin—Shock—Pregabalin—epilepsy syndrome	0.000103	0.000583	CcSEcCtD
Prazosin—Somnolence—Valproic Acid—epilepsy syndrome	0.000103	0.000582	CcSEcCtD
Prazosin—ABCB1—spinal cord—epilepsy syndrome	0.000102	0.00134	CbGeAlD
Prazosin—Tachycardia—Pregabalin—epilepsy syndrome	0.000102	0.000578	CcSEcCtD
Prazosin—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000101	0.000573	CcSEcCtD
Prazosin—Vomiting—Clonazepam—epilepsy syndrome	0.000101	0.000572	CcSEcCtD
Prazosin—Alopecia—Topiramate—epilepsy syndrome	0.0001	0.000568	CcSEcCtD
Prazosin—Vomiting—Phenytoin—epilepsy syndrome	0.0001	0.000568	CcSEcCtD
Prazosin—Rash—Clonazepam—epilepsy syndrome	0.0001	0.000567	CcSEcCtD
Prazosin—Dermatitis—Clonazepam—epilepsy syndrome	9.99e-05	0.000567	CcSEcCtD
Prazosin—Arthralgia—Gabapentin—epilepsy syndrome	9.99e-05	0.000567	CcSEcCtD
Prazosin—Nausea—Felbamate—epilepsy syndrome	9.99e-05	0.000566	CcSEcCtD
Prazosin—Vomiting—Oxcarbazepine—epilepsy syndrome	9.97e-05	0.000565	CcSEcCtD
Prazosin—Fatigue—Valproic Acid—epilepsy syndrome	9.96e-05	0.000565	CcSEcCtD
Prazosin—Dizziness—Carbamazepine—epilepsy syndrome	9.95e-05	0.000564	CcSEcCtD
Prazosin—Diarrhoea—Lamotrigine—epilepsy syndrome	9.95e-05	0.000564	CcSEcCtD
Prazosin—Headache—Clonazepam—epilepsy syndrome	9.94e-05	0.000564	CcSEcCtD
Prazosin—Rash—Phenytoin—epilepsy syndrome	9.93e-05	0.000563	CcSEcCtD
Prazosin—Dermatitis—Phenytoin—epilepsy syndrome	9.93e-05	0.000563	CcSEcCtD
Prazosin—Rash—Oxcarbazepine—epilepsy syndrome	9.88e-05	0.00056	CcSEcCtD
Prazosin—Constipation—Valproic Acid—epilepsy syndrome	9.88e-05	0.00056	CcSEcCtD
Prazosin—Pain—Valproic Acid—epilepsy syndrome	9.88e-05	0.00056	CcSEcCtD
Prazosin—Dermatitis—Oxcarbazepine—epilepsy syndrome	9.87e-05	0.00056	CcSEcCtD
Prazosin—Headache—Phenytoin—epilepsy syndrome	9.87e-05	0.00056	CcSEcCtD
Prazosin—Discomfort—Gabapentin—epilepsy syndrome	9.87e-05	0.00056	CcSEcCtD
Prazosin—Headache—Oxcarbazepine—epilepsy syndrome	9.82e-05	0.000557	CcSEcCtD
Prazosin—Nausea—Zonisamide—epilepsy syndrome	9.78e-05	0.000554	CcSEcCtD
Prazosin—Dry mouth—Gabapentin—epilepsy syndrome	9.77e-05	0.000554	CcSEcCtD
Prazosin—Tension—Topiramate—epilepsy syndrome	9.69e-05	0.000549	CcSEcCtD
Prazosin—Dizziness—Lamotrigine—epilepsy syndrome	9.61e-05	0.000545	CcSEcCtD
Prazosin—Nervousness—Topiramate—epilepsy syndrome	9.59e-05	0.000544	CcSEcCtD
Prazosin—Oedema—Gabapentin—epilepsy syndrome	9.58e-05	0.000543	CcSEcCtD
Prazosin—Vomiting—Carbamazepine—epilepsy syndrome	9.56e-05	0.000542	CcSEcCtD
Prazosin—Feeling abnormal—Valproic Acid—epilepsy syndrome	9.52e-05	0.00054	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	9.51e-05	0.00054	CcSEcCtD
Prazosin—Rash—Carbamazepine—epilepsy syndrome	9.48e-05	0.000538	CcSEcCtD
Prazosin—Dermatitis—Carbamazepine—epilepsy syndrome	9.47e-05	0.000537	CcSEcCtD
Prazosin—Insomnia—Pregabalin—epilepsy syndrome	9.44e-05	0.000536	CcSEcCtD
Prazosin—Nausea—Clonazepam—epilepsy syndrome	9.42e-05	0.000534	CcSEcCtD
Prazosin—Headache—Carbamazepine—epilepsy syndrome	9.42e-05	0.000534	CcSEcCtD
Prazosin—Shock—Gabapentin—epilepsy syndrome	9.42e-05	0.000534	CcSEcCtD
Prazosin—Paraesthesia—Pregabalin—epilepsy syndrome	9.38e-05	0.000532	CcSEcCtD
Prazosin—Nausea—Phenytoin—epilepsy syndrome	9.36e-05	0.000531	CcSEcCtD
Prazosin—Tachycardia—Gabapentin—epilepsy syndrome	9.35e-05	0.00053	CcSEcCtD
Prazosin—Dyspnoea—Pregabalin—epilepsy syndrome	9.31e-05	0.000528	CcSEcCtD
Prazosin—Nausea—Oxcarbazepine—epilepsy syndrome	9.31e-05	0.000528	CcSEcCtD
Prazosin—Vision blurred—Topiramate—epilepsy syndrome	9.3e-05	0.000528	CcSEcCtD
Prazosin—Somnolence—Pregabalin—epilepsy syndrome	9.28e-05	0.000527	CcSEcCtD
Prazosin—Hyperhidrosis—Gabapentin—epilepsy syndrome	9.26e-05	0.000525	CcSEcCtD
Prazosin—Vomiting—Lamotrigine—epilepsy syndrome	9.24e-05	0.000524	CcSEcCtD
Prazosin—Urticaria—Valproic Acid—epilepsy syndrome	9.18e-05	0.00052	CcSEcCtD
Prazosin—Rash—Lamotrigine—epilepsy syndrome	9.16e-05	0.00052	CcSEcCtD
Prazosin—Ill-defined disorder—Topiramate—epilepsy syndrome	9.16e-05	0.000519	CcSEcCtD
Prazosin—Dermatitis—Lamotrigine—epilepsy syndrome	9.16e-05	0.000519	CcSEcCtD
Prazosin—Body temperature increased—Valproic Acid—epilepsy syndrome	9.13e-05	0.000518	CcSEcCtD
Prazosin—Headache—Lamotrigine—epilepsy syndrome	9.11e-05	0.000516	CcSEcCtD
Prazosin—ABCB1—head—epilepsy syndrome	9.1e-05	0.00119	CbGeAlD
Prazosin—Fatigue—Pregabalin—epilepsy syndrome	9e-05	0.000511	CcSEcCtD
Prazosin—Nausea—Carbamazepine—epilepsy syndrome	8.93e-05	0.000507	CcSEcCtD
Prazosin—Pain—Pregabalin—epilepsy syndrome	8.93e-05	0.000506	CcSEcCtD
Prazosin—Constipation—Pregabalin—epilepsy syndrome	8.93e-05	0.000506	CcSEcCtD
Prazosin—Malaise—Topiramate—epilepsy syndrome	8.9e-05	0.000505	CcSEcCtD
Prazosin—Vertigo—Topiramate—epilepsy syndrome	8.87e-05	0.000503	CcSEcCtD
Prazosin—Syncope—Topiramate—epilepsy syndrome	8.85e-05	0.000502	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	8.72e-05	0.000495	CcSEcCtD
Prazosin—Palpitations—Topiramate—epilepsy syndrome	8.72e-05	0.000495	CcSEcCtD
Prazosin—Loss of consciousness—Topiramate—epilepsy syndrome	8.68e-05	0.000492	CcSEcCtD
Prazosin—Insomnia—Gabapentin—epilepsy syndrome	8.66e-05	0.000491	CcSEcCtD
Prazosin—Nausea—Lamotrigine—epilepsy syndrome	8.63e-05	0.00049	CcSEcCtD
Prazosin—ABCB1—nervous system—epilepsy syndrome	8.63e-05	0.00113	CbGeAlD
Prazosin—Feeling abnormal—Pregabalin—epilepsy syndrome	8.6e-05	0.000488	CcSEcCtD
Prazosin—Paraesthesia—Gabapentin—epilepsy syndrome	8.6e-05	0.000488	CcSEcCtD
Prazosin—Dyspnoea—Gabapentin—epilepsy syndrome	8.54e-05	0.000484	CcSEcCtD
Prazosin—Somnolence—Gabapentin—epilepsy syndrome	8.51e-05	0.000483	CcSEcCtD
Prazosin—Hypersensitivity—Valproic Acid—epilepsy syndrome	8.51e-05	0.000483	CcSEcCtD
Prazosin—Arthralgia—Topiramate—epilepsy syndrome	8.4e-05	0.000477	CcSEcCtD
Prazosin—ABCB1—central nervous system—epilepsy syndrome	8.3e-05	0.00109	CbGeAlD
Prazosin—Discomfort—Topiramate—epilepsy syndrome	8.3e-05	0.000471	CcSEcCtD
Prazosin—Urticaria—Pregabalin—epilepsy syndrome	8.3e-05	0.00047	CcSEcCtD
Prazosin—Asthenia—Valproic Acid—epilepsy syndrome	8.29e-05	0.00047	CcSEcCtD
Prazosin—Fatigue—Gabapentin—epilepsy syndrome	8.26e-05	0.000468	CcSEcCtD
Prazosin—Body temperature increased—Pregabalin—epilepsy syndrome	8.25e-05	0.000468	CcSEcCtD
Prazosin—Dry mouth—Topiramate—epilepsy syndrome	8.22e-05	0.000466	CcSEcCtD
Prazosin—Pain—Gabapentin—epilepsy syndrome	8.19e-05	0.000464	CcSEcCtD
Prazosin—Constipation—Gabapentin—epilepsy syndrome	8.19e-05	0.000464	CcSEcCtD
Prazosin—Pruritus—Valproic Acid—epilepsy syndrome	8.17e-05	0.000463	CcSEcCtD
Prazosin—ABCB1—cerebellum—epilepsy syndrome	8.12e-05	0.00106	CbGeAlD
Prazosin—Oedema—Topiramate—epilepsy syndrome	8.06e-05	0.000457	CcSEcCtD
Prazosin—Shock—Topiramate—epilepsy syndrome	7.93e-05	0.00045	CcSEcCtD
Prazosin—Diarrhoea—Valproic Acid—epilepsy syndrome	7.9e-05	0.000448	CcSEcCtD
Prazosin—Feeling abnormal—Gabapentin—epilepsy syndrome	7.89e-05	0.000448	CcSEcCtD
Prazosin—Tachycardia—Topiramate—epilepsy syndrome	7.86e-05	0.000446	CcSEcCtD
Prazosin—Hyperhidrosis—Topiramate—epilepsy syndrome	7.79e-05	0.000442	CcSEcCtD
Prazosin—Hypersensitivity—Pregabalin—epilepsy syndrome	7.69e-05	0.000436	CcSEcCtD
Prazosin—Dizziness—Valproic Acid—epilepsy syndrome	7.64e-05	0.000433	CcSEcCtD
Prazosin—Urticaria—Gabapentin—epilepsy syndrome	7.61e-05	0.000431	CcSEcCtD
Prazosin—Body temperature increased—Gabapentin—epilepsy syndrome	7.57e-05	0.000429	CcSEcCtD
Prazosin—Asthenia—Pregabalin—epilepsy syndrome	7.49e-05	0.000425	CcSEcCtD
Prazosin—Pruritus—Pregabalin—epilepsy syndrome	7.39e-05	0.000419	CcSEcCtD
Prazosin—Vomiting—Valproic Acid—epilepsy syndrome	7.34e-05	0.000417	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	7.34e-05	0.000416	CcSEcCtD
Prazosin—Insomnia—Topiramate—epilepsy syndrome	7.29e-05	0.000413	CcSEcCtD
Prazosin—Rash—Valproic Acid—epilepsy syndrome	7.28e-05	0.000413	CcSEcCtD
Prazosin—Dermatitis—Valproic Acid—epilepsy syndrome	7.28e-05	0.000413	CcSEcCtD
Prazosin—Headache—Valproic Acid—epilepsy syndrome	7.24e-05	0.00041	CcSEcCtD
Prazosin—Paraesthesia—Topiramate—epilepsy syndrome	7.23e-05	0.00041	CcSEcCtD
Prazosin—Dyspnoea—Topiramate—epilepsy syndrome	7.18e-05	0.000407	CcSEcCtD
Prazosin—Somnolence—Topiramate—epilepsy syndrome	7.16e-05	0.000406	CcSEcCtD
Prazosin—Diarrhoea—Pregabalin—epilepsy syndrome	7.14e-05	0.000405	CcSEcCtD
Prazosin—Hypersensitivity—Gabapentin—epilepsy syndrome	7.05e-05	0.0004	CcSEcCtD
Prazosin—Fatigue—Topiramate—epilepsy syndrome	6.95e-05	0.000394	CcSEcCtD
Prazosin—Dizziness—Pregabalin—epilepsy syndrome	6.91e-05	0.000392	CcSEcCtD
Prazosin—Pain—Topiramate—epilepsy syndrome	6.89e-05	0.000391	CcSEcCtD
Prazosin—Constipation—Topiramate—epilepsy syndrome	6.89e-05	0.000391	CcSEcCtD
Prazosin—Asthenia—Gabapentin—epilepsy syndrome	6.87e-05	0.00039	CcSEcCtD
Prazosin—Nausea—Valproic Acid—epilepsy syndrome	6.86e-05	0.000389	CcSEcCtD
Prazosin—Pruritus—Gabapentin—epilepsy syndrome	6.77e-05	0.000384	CcSEcCtD
Prazosin—Vomiting—Pregabalin—epilepsy syndrome	6.64e-05	0.000377	CcSEcCtD
Prazosin—Feeling abnormal—Topiramate—epilepsy syndrome	6.64e-05	0.000377	CcSEcCtD
Prazosin—ABCB1—brain—epilepsy syndrome	6.59e-05	0.000863	CbGeAlD
Prazosin—Rash—Pregabalin—epilepsy syndrome	6.58e-05	0.000373	CcSEcCtD
Prazosin—Dermatitis—Pregabalin—epilepsy syndrome	6.58e-05	0.000373	CcSEcCtD
Prazosin—Diarrhoea—Gabapentin—epilepsy syndrome	6.55e-05	0.000372	CcSEcCtD
Prazosin—Headache—Pregabalin—epilepsy syndrome	6.54e-05	0.000371	CcSEcCtD
Prazosin—Urticaria—Topiramate—epilepsy syndrome	6.4e-05	0.000363	CcSEcCtD
Prazosin—Body temperature increased—Topiramate—epilepsy syndrome	6.37e-05	0.000361	CcSEcCtD
Prazosin—Dizziness—Gabapentin—epilepsy syndrome	6.33e-05	0.000359	CcSEcCtD
Prazosin—Nausea—Pregabalin—epilepsy syndrome	6.2e-05	0.000352	CcSEcCtD
Prazosin—Vomiting—Gabapentin—epilepsy syndrome	6.09e-05	0.000345	CcSEcCtD
Prazosin—Rash—Gabapentin—epilepsy syndrome	6.04e-05	0.000342	CcSEcCtD
Prazosin—Dermatitis—Gabapentin—epilepsy syndrome	6.03e-05	0.000342	CcSEcCtD
Prazosin—Headache—Gabapentin—epilepsy syndrome	6e-05	0.00034	CcSEcCtD
Prazosin—Hypersensitivity—Topiramate—epilepsy syndrome	5.94e-05	0.000337	CcSEcCtD
Prazosin—Asthenia—Topiramate—epilepsy syndrome	5.78e-05	0.000328	CcSEcCtD
Prazosin—Pruritus—Topiramate—epilepsy syndrome	5.7e-05	0.000323	CcSEcCtD
Prazosin—Nausea—Gabapentin—epilepsy syndrome	5.69e-05	0.000323	CcSEcCtD
Prazosin—Diarrhoea—Topiramate—epilepsy syndrome	5.51e-05	0.000313	CcSEcCtD
Prazosin—Dizziness—Topiramate—epilepsy syndrome	5.33e-05	0.000302	CcSEcCtD
Prazosin—Vomiting—Topiramate—epilepsy syndrome	5.12e-05	0.00029	CcSEcCtD
Prazosin—Rash—Topiramate—epilepsy syndrome	5.08e-05	0.000288	CcSEcCtD
Prazosin—Dermatitis—Topiramate—epilepsy syndrome	5.07e-05	0.000288	CcSEcCtD
Prazosin—Headache—Topiramate—epilepsy syndrome	5.05e-05	0.000286	CcSEcCtD
Prazosin—Nausea—Topiramate—epilepsy syndrome	4.79e-05	0.000271	CcSEcCtD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.61e-06	1.72e-05	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—VEGFA—epilepsy syndrome	2.61e-06	1.72e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—IL6ST—epilepsy syndrome	2.61e-06	1.71e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—AKT3—epilepsy syndrome	2.58e-06	1.7e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—JUNB—epilepsy syndrome	2.58e-06	1.7e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CNR1—epilepsy syndrome	2.58e-06	1.7e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—HTR2A—epilepsy syndrome	2.57e-06	1.69e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PLCB1—epilepsy syndrome	2.57e-06	1.69e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—FYN—epilepsy syndrome	2.57e-06	1.69e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—AVP—epilepsy syndrome	2.57e-06	1.69e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—POMC—epilepsy syndrome	2.56e-06	1.69e-05	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—AGT—epilepsy syndrome	2.56e-06	1.68e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—H2AFX—epilepsy syndrome	2.56e-06	1.68e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—HMOX1—epilepsy syndrome	2.56e-06	1.68e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—MEF2C—epilepsy syndrome	2.55e-06	1.68e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—HES1—epilepsy syndrome	2.55e-06	1.68e-05	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—AGT—epilepsy syndrome	2.53e-06	1.66e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—CAT—epilepsy syndrome	2.52e-06	1.66e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—ADAM10—epilepsy syndrome	2.52e-06	1.66e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—HTR7—epilepsy syndrome	2.52e-06	1.65e-05	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.51e-06	1.65e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—CCL2—epilepsy syndrome	2.51e-06	1.65e-05	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—APOE—epilepsy syndrome	2.51e-06	1.65e-05	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—APOE—epilepsy syndrome	2.48e-06	1.63e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—FYN—epilepsy syndrome	2.48e-06	1.63e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—H2AFX—epilepsy syndrome	2.47e-06	1.62e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—YWHAZ—epilepsy syndrome	2.47e-06	1.62e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—MEF2C—epilepsy syndrome	2.47e-06	1.62e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—ABCB1—epilepsy syndrome	2.45e-06	1.61e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—TSC2—epilepsy syndrome	2.44e-06	1.61e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—HBEGF—epilepsy syndrome	2.44e-06	1.61e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—AGT—epilepsy syndrome	2.44e-06	1.61e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—NGF—epilepsy syndrome	2.44e-06	1.6e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—HES1—epilepsy syndrome	2.43e-06	1.6e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—POMC—epilepsy syndrome	2.4e-06	1.58e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—AKT3—epilepsy syndrome	2.4e-06	1.58e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—APOE—epilepsy syndrome	2.39e-06	1.57e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—S100B—epilepsy syndrome	2.38e-06	1.57e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—POMC—epilepsy syndrome	2.38e-06	1.57e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—YWHAZ—epilepsy syndrome	2.38e-06	1.57e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	2.38e-06	1.56e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CCR5—epilepsy syndrome	2.37e-06	1.56e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—SOCS3—epilepsy syndrome	2.36e-06	1.55e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—FYN—epilepsy syndrome	2.36e-06	1.55e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—AGT—epilepsy syndrome	2.36e-06	1.55e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—NGF—epilepsy syndrome	2.36e-06	1.55e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CDC42—epilepsy syndrome	2.36e-06	1.55e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—H2AFX—epilepsy syndrome	2.35e-06	1.55e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CCL2—epilepsy syndrome	2.35e-06	1.54e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—MEF2C—epilepsy syndrome	2.35e-06	1.54e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—KDR—epilepsy syndrome	2.34e-06	1.54e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—ADAM10—epilepsy syndrome	2.34e-06	1.54e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—CCL2—epilepsy syndrome	2.33e-06	1.53e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—HTR2A—epilepsy syndrome	2.32e-06	1.53e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—APOE—epilepsy syndrome	2.31e-06	1.52e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CCR5—epilepsy syndrome	2.29e-06	1.51e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—GPX1—epilepsy syndrome	2.28e-06	1.5e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—AVP—epilepsy syndrome	2.28e-06	1.5e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—YWHAZ—epilepsy syndrome	2.27e-06	1.49e-05	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.27e-06	1.49e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	2.26e-06	1.49e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—PRKCB—epilepsy syndrome	2.26e-06	1.48e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—BCHE—epilepsy syndrome	2.25e-06	1.48e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—IL6ST—epilepsy syndrome	2.25e-06	1.48e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—NGF—epilepsy syndrome	2.24e-06	1.48e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—HTR2A—epilepsy syndrome	2.24e-06	1.47e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—S100B—epilepsy syndrome	2.22e-06	1.46e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—HMOX1—epilepsy syndrome	2.21e-06	1.46e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—TSC2—epilepsy syndrome	2.21e-06	1.45e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—AGT—epilepsy syndrome	2.2e-06	1.45e-05	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—AKT1—epilepsy syndrome	2.19e-06	1.44e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—SOCS3—epilepsy syndrome	2.19e-06	1.44e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CDC42—epilepsy syndrome	2.19e-06	1.44e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—CAT—epilepsy syndrome	2.18e-06	1.44e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CCR5—epilepsy syndrome	2.18e-06	1.44e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—APOE—epilepsy syndrome	2.16e-06	1.42e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—HES1—epilepsy syndrome	2.16e-06	1.42e-05	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—POMC—epilepsy syndrome	2.15e-06	1.42e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	2.15e-06	1.41e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—HTR2A—epilepsy syndrome	2.14e-06	1.4e-05	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—POMC—epilepsy syndrome	2.13e-06	1.4e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—TSC2—epilepsy syndrome	2.13e-06	1.4e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—AGT—epilepsy syndrome	2.13e-06	1.4e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PLCB1—epilepsy syndrome	2.13e-06	1.4e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	2.12e-06	1.4e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—FGF2—epilepsy syndrome	2.12e-06	1.4e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—AVP—epilepsy syndrome	2.12e-06	1.39e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—TH—epilepsy syndrome	2.12e-06	1.39e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—KDR—epilepsy syndrome	2.12e-06	1.39e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—FYN—epilepsy syndrome	2.1e-06	1.38e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—H2AFX—epilepsy syndrome	2.09e-06	1.37e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MEF2C—epilepsy syndrome	2.09e-06	1.37e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—APOE—epilepsy syndrome	2.08e-06	1.37e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—POMC—epilepsy syndrome	2.06e-06	1.35e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—KDR—epilepsy syndrome	2.04e-06	1.34e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—PRKCB—epilepsy syndrome	2.04e-06	1.34e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—TSC2—epilepsy syndrome	2.03e-06	1.33e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IL6ST—epilepsy syndrome	2.03e-06	1.33e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—AGT—epilepsy syndrome	2.03e-06	1.33e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—YWHAZ—epilepsy syndrome	2.02e-06	1.33e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CCL2—epilepsy syndrome	2.01e-06	1.32e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—HES1—epilepsy syndrome	2e-06	1.32e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—AGT—epilepsy syndrome	2e-06	1.32e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—NGF—epilepsy syndrome	1.99e-06	1.31e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—POMC—epilepsy syndrome	1.99e-06	1.31e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—APOE—epilepsy syndrome	1.99e-06	1.31e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—GPX1—epilepsy syndrome	1.97e-06	1.3e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—RELA—epilepsy syndrome	1.97e-06	1.3e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	1.97e-06	1.29e-05	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—ALB—epilepsy syndrome	1.96e-06	1.29e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—APOE—epilepsy syndrome	1.96e-06	1.29e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	1.96e-06	1.29e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—FYN—epilepsy syndrome	1.95e-06	1.28e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—KDR—epilepsy syndrome	1.95e-06	1.28e-05	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—ALB—epilepsy syndrome	1.94e-06	1.28e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—H2AFX—epilepsy syndrome	1.94e-06	1.28e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CCR5—epilepsy syndrome	1.94e-06	1.27e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MEF2C—epilepsy syndrome	1.94e-06	1.27e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—MTOR—epilepsy syndrome	1.93e-06	1.27e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—HTR2A—epilepsy syndrome	1.9e-06	1.25e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.87e-06	1.23e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PRKCB—epilepsy syndrome	1.87e-06	1.23e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IL6ST—epilepsy syndrome	1.86e-06	1.23e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—POMC—epilepsy syndrome	1.86e-06	1.22e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	1.85e-06	1.22e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—FGF2—epilepsy syndrome	1.82e-06	1.19e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CCL2—epilepsy syndrome	1.82e-06	1.19e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—ALB—epilepsy syndrome	1.81e-06	1.19e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—TSC2—epilepsy syndrome	1.8e-06	1.19e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	1.8e-06	1.18e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—AGT—epilepsy syndrome	1.8e-06	1.18e-05	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—AKT1—epilepsy syndrome	1.79e-06	1.18e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	1.79e-06	1.18e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CASP3—epilepsy syndrome	1.78e-06	1.17e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.77e-06	1.16e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—APOE—epilepsy syndrome	1.76e-06	1.16e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	1.76e-06	1.16e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	1.75e-06	1.15e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CAT—epilepsy syndrome	1.74e-06	1.15e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—AGT—epilepsy syndrome	1.73e-06	1.14e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	1.73e-06	1.14e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—JUN—epilepsy syndrome	1.73e-06	1.14e-05	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—PTGS2—epilepsy syndrome	1.72e-06	1.13e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—POMC—epilepsy syndrome	1.71e-06	1.12e-05	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—PTGS2—epilepsy syndrome	1.7e-06	1.12e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—APOE—epilepsy syndrome	1.7e-06	1.12e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—RELA—epilepsy syndrome	1.69e-06	1.11e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—POMC—epilepsy syndrome	1.68e-06	1.11e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—MMP9—epilepsy syndrome	1.68e-06	1.1e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	1.67e-06	1.1e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	1.67e-06	1.1e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CCL2—epilepsy syndrome	1.67e-06	1.1e-05	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	1.66e-06	1.09e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	1.66e-06	1.09e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	1.66e-06	1.09e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—MTOR—epilepsy syndrome	1.65e-06	1.09e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—FGF2—epilepsy syndrome	1.64e-06	1.08e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	1.64e-06	1.08e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—AKT1—epilepsy syndrome	1.63e-06	1.07e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	1.61e-06	1.06e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—PTGS2—epilepsy syndrome	1.58e-06	1.04e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	1.58e-06	1.04e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.58e-06	1.04e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—SRC—epilepsy syndrome	1.55e-06	1.02e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	1.55e-06	1.02e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	1.54e-06	1.01e-05	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—AKT1—epilepsy syndrome	1.54e-06	1.01e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—ALB—epilepsy syndrome	1.53e-06	1.01e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	1.52e-06	1e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CASP3—epilepsy syndrome	1.52e-06	1e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	1.52e-06	9.96e-06	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—VEGFA—epilepsy syndrome	1.51e-06	9.92e-06	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	1.51e-06	9.92e-06	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	1.49e-06	9.82e-06	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	1.48e-06	9.75e-06	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—JUN—epilepsy syndrome	1.48e-06	9.72e-06	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	1.47e-06	9.67e-06	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—POMC—epilepsy syndrome	1.46e-06	9.58e-06	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	1.44e-06	9.48e-06	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—MMP9—epilepsy syndrome	1.44e-06	9.46e-06	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	1.41e-06	9.26e-06	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	1.4e-06	9.21e-06	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—AKT1—epilepsy syndrome	1.39e-06	9.17e-06	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.39e-06	9.12e-06	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—AGT—epilepsy syndrome	1.38e-06	9.09e-06	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	1.38e-06	9.06e-06	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	1.37e-06	9.03e-06	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	1.37e-06	9.03e-06	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—AKT1—epilepsy syndrome	1.36e-06	8.96e-06	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—APOE—epilepsy syndrome	1.36e-06	8.91e-06	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	1.34e-06	8.83e-06	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	1.34e-06	8.81e-06	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.34e-06	8.8e-06	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	1.33e-06	8.77e-06	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—ALB—epilepsy syndrome	1.33e-06	8.74e-06	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	1.33e-06	8.72e-06	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—SRC—epilepsy syndrome	1.33e-06	8.72e-06	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	1.3e-06	8.54e-06	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—VEGFA—epilepsy syndrome	1.29e-06	8.49e-06	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	1.29e-06	8.47e-06	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.27e-06	8.38e-06	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	1.26e-06	8.3e-06	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	1.26e-06	8.28e-06	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	1.25e-06	8.24e-06	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	1.24e-06	8.19e-06	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	1.24e-06	8.18e-06	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	1.23e-06	8.07e-06	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	1.22e-06	8.02e-06	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	1.22e-06	7.99e-06	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	1.2e-06	7.87e-06	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	1.19e-06	7.85e-06	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	1.17e-06	7.67e-06	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—POMC—epilepsy syndrome	1.16e-06	7.66e-06	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	1.16e-06	7.64e-06	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	1.16e-06	7.61e-06	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	1.16e-06	7.6e-06	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	1.16e-06	7.6e-06	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	1.13e-06	7.45e-06	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.13e-06	7.44e-06	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	1.13e-06	7.4e-06	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	1.12e-06	7.38e-06	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	1.1e-06	7.24e-06	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	1.09e-06	7.16e-06	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	1.07e-06	7.05e-06	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—ALB—epilepsy syndrome	1.06e-06	6.98e-06	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	1.06e-06	6.97e-06	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.05e-06	6.92e-06	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	1.04e-06	6.85e-06	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	1.03e-06	6.76e-06	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	1.01e-06	6.66e-06	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	9.85e-07	6.48e-06	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	9.77e-07	6.43e-06	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—AKT1—epilepsy syndrome	9.63e-07	6.33e-06	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	9.55e-07	6.28e-06	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	9.52e-07	6.26e-06	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PTGS2—epilepsy syndrome	9.29e-07	6.11e-06	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	9.08e-07	5.97e-06	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	8.84e-07	5.82e-06	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—AKT1—epilepsy syndrome	8.63e-07	5.68e-06	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—AKT1—epilepsy syndrome	8.54e-07	5.62e-06	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—AKT1—epilepsy syndrome	8.24e-07	5.42e-06	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—AKT1—epilepsy syndrome	7.96e-07	5.24e-06	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	7.44e-07	4.89e-06	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	7.18e-07	4.72e-06	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	6.84e-07	4.5e-06	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—AKT1—epilepsy syndrome	6.75e-07	4.44e-06	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	6.07e-07	3.99e-06	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—AKT1—epilepsy syndrome	5.84e-07	3.84e-06	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	5.64e-07	3.71e-06	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—AKT1—epilepsy syndrome	4.67e-07	3.07e-06	CbGpPWpGaD
